Global IGY Polyclonal Antibodies Market Size, Status and Forecast 2021-2027

Immunoglobulin Y (abbreviated as IgY) is a type of immunoglobulin which is the major antibody in bird, reptile, and lungfish blood. It is also found in high concentrations in chicken egg yolk. As with the other immunoglobulins, IgY is a class of proteins which are formed by the immune system in reaction to certain foreign substances, and specifically recognize them.
IgY antibodies have a different structure from IgG, particularly in the Fc and hinge regions. The affinity maturation process of IgY is also different from IgG. These biological features underlie IgY's competitive advantages over IgG. Shown in the four panels are several comparisons between IgY and IgG.
IgY is a hen egg polyclonal antibody. Hen eggs contain more than 450 separate antibodies and when consumed, are not rejected by the human immune system.
North America is the largest consumption place, with a consumption market share nearly 37.5% in 2017; Europe is the second largest consumption place with the consumption market share of 30% in 2017.

Market Analysis and Insights: Global IGY Polyclonal Antibodies Market
The global IGY Polyclonal Antibodies market size is projected to reach US$ 16 million by 2027, from US$ 7 million in 2020, at a CAGR of 13.4% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global IGY Polyclonal Antibodies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global IGY Polyclonal Antibodies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global IGY Polyclonal Antibodies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global IGY Polyclonal Antibodies market.

Global IGY Polyclonal Antibodies Scope and Market Size
IGY Polyclonal Antibodies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global IGY Polyclonal Antibodies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Primary Antibody
Secondary Antibody

Segment by Application
Academic Research
Commercial

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck
IGY Life Sciences
Abcam
Genway Biotech
Good Biotech
Gallus Immunotech
Creative Diagnostics
Agrisera
Innovagen AB
Capra Science
YO Proteins
GeneTex

Frequently Asked Questions